Online citations, reference lists, and bibliographies.
← Back to Search

Successful Intravenous Thrombolysis In A 14-year-old Boy With Ischemic Stroke.

Isabel Sampaio, F. Abecasis, S. Quintas, T. Moreno, C. Camilo, Marisa Vieira, T. Pinho e Melo, M. Correia
Published 2011 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
We report a healthy 14-year-old boy with an acute left middle cerebral artery stroke, treated 2 hours after the onset of symptoms with intravenous recombinant tissue plasminogen activator (r-TPA). Recanalization of the middle cerebral artery was documented with transcranial Doppler during the first 5 minutes of intravenous r-TPA perfusion, and progressive recovery of the neurological deficits occurred. Although lack of evidence regarding safety and efficacy in children precludes the recommendation of systematic use of r-TPA in pediatric stroke, we propose that this option should be considered and discussed with the parents, especially in older children presenting within 3 hours in centers with experience in adult thrombolysis.
This paper references
10.1016/S1474-4422(09)70106-1
Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study
Catherine M. Amlie-Lefond (2009)
10.1056/nejm199512143332401
Tissue plasminogen activator for acute ischemic stroke.
Koroshetz Wj (1995)
10.1017/S1481803500010824
Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature.
S. Cremer (2008)
10.1055/S-0038-1656042
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.
A. Catto (1997)
10.1046/j.1365-2141.2000.02164.x
The 4G/4G genotype at nucleotide position −675 in the promotor region of the plasminogen activator inhibitor 1 (PAI‐1) gene is less frequent in young patients with minor stroke than in controls
G. Endler (2000)
10.1056/NEJM199512143332401
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
J. Grotta (1995)
10.1161/01.STR.0000174485.10277.24
Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of Stroke: Replicated Findings in Two Nested Case–Control Studies Based on Independent Cohorts
P. Wiklund (2005)
10.1080/08880010902773230
THROMBOLYTICS FOR HYPERACUTE STROKE IN CHILDREN
Catherine M. Amlie-Lefond (2009)
10.1007/978-1-4471-3115-1
The Elderly
Frcp W. J. MacLennan MD (1984)
10.1177/174182670200900209
The Association of PAI-1 Promoter 4G/5G Insertion/Deletion Polymorphism with Myocardial Infarction and Stroke in Young Women
L. Hindorff (2002)
10.1161/STROKEAHA.108.189696
Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.
E. Roach (2008)
Thrombolysis for Ischemic Stroke in ChildrenVdata from the nationwide inpatient sample. Stroke
N Janjua (2007)
10.1177/088307380001500508
Neurologic Outcome in Survivors of Childhood Arterial Ischemic Stroke and Sinovenous Thrombosis
G. DeVeber (2000)
10.1161/CIRCULATIONAHA.107.181486
Guidelines for the Early Management of Adults With Ischemic Stroke
H. Adams (2007)
10.1016/j.jns.2007.03.028
Clinically successful late recanalization of basilar artery occlusion in childhood: What are the odds?: Case report and review of the literature
Savvas Grigoriadis (2007)
Patent foramen ovale and cryptogenic stroke: to close or not to close? Circulation. 2008;118:1989Y1997
S Windecker (2011)
Management of Stroke in Infants and Children
S. Roach (2008)
10.1161/STROKEAHA.106.473983
Thrombolysis for Ischemic Stroke in Children: Data From the Nationwide Inpatient Sample
N. Janjua (2007)
Patent foramen ovale and cryptogenic stroke: to close or not to close? Circulation
S Windecker (2008)
10.1016/J.ARCPED.2008.07.005
L’utilisation de la thrombolyse intraveineuse dans l’infarctus cérébral artériel aigu de l’enfant, en dehors de la période néonatale : à propos d’un cas et revue de la littérature
H. Bourdial (2008)
10.1016/S1474-4422(09)70111-5
Thrombolysis in childhood ischaemic stroke: still a bridge too far
K. Braun (2009)
10.1016/j.arcped.2008.07.005
[Intravenous thrombolysis in pediatric arterial ischemic stroke: a case report and a review of the literature].
H. Bourdial (2008)
10.1161/01.STR.0000098004.26252.EB
4G/4G Genotype of PAI-1 Gene Is Associated With Reduced Risk of Stroke in Elderly
T. Hoekstra (2003)
10.1161/01.CIR.101.1.67
Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women.
M. Roest (2000)
Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke
P Wiklund (2005)
Thrombolysis in Childhood StrokeVreport of 2 cases and review of the literature. Stroke
M Arnold (2009)
10.1542/PEDS.110.5.924
Time lag to diagnosis of stroke in children.
L. Gabis (2002)
10.1159/000047656
4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Insertion/Deletion Polymorphism of the Tissue-Type Plasminogen Activator Gene in Atherothrombotic Stroke
C. Bang (2001)
Patent foramen ovale in cryptogenic stroke: to close or not to close?
K. Subramanyam (2006)
10.1542/PEDS.109.1.116
Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke.
J. Lynch (2002)
10.1161/CIRCULATIONAHA.107.757013
Patent Foramen Ovale and Cryptogenic Stroke: To Close or Not to Close?: Closure: What Else!
S. Windecker (2008)
in Children V data from the nationwide inpatient sample
S Grigoriadis (2007)
10.1161/STROKEAHA.108.529560
Thrombolysis in Childhood Stroke: Report of 2 Cases and Review of the Literature
M. Arnold (2009)
Thrombolysis in Childhood StrokeVreport of 2 cases and review of the literature
M Arnold (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar